TY  - GEN
AU  - Sablin,M P
AU  - Negrier,S
AU  - Ravaud,A
AU  - Oudard,S
AU  - Balleyguier,C
AU  - Gautier,J
AU  - Celier,C
AU  - Medioni,J
AU  - Escudier,B
TI  - Sequential sorafenib and sunitinib for renal cell carcinoma
SN  - 1527-3792
PY  - 2010///0701
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - administration & dosage
KW  - Benzenesulfonates
KW  - Carcinoma, Renal Cell
KW  - drug therapy
KW  - Cohort Studies
KW  - Disease-Free Survival
KW  - Dose-Response Relationship, Drug
KW  - Drug Administration Schedule
KW  - Drug Interactions
KW  - Female
KW  - Follow-Up Studies
KW  - Humans
KW  - Indoles
KW  - Kaplan-Meier Estimate
KW  - Kidney Neoplasms
KW  - Male
KW  - Middle Aged
KW  - Neoplasm Invasiveness
KW  - pathology
KW  - Neoplasm Metastasis
KW  - Niacinamide
KW  - analogs & derivatives
KW  - Phenylurea Compounds
KW  - Probability
KW  - Pyridines
KW  - Pyrroles
KW  - Retrospective Studies
KW  - Risk Assessment
KW  - Sorafenib
KW  - Sunitinib
KW  - Survival Analysis
KW  - Treatment Outcome
N1  - Publication Type: Comparative Study; Journal Article; Multicenter Study
UR  - https://doi.org/10.1016/j.juro.2009.02.119
ER  -